BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 27353753)

  • 21. Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.
    Arrecubieta C; Matsunaga I; Asai T; Naka Y; Deng MC; Lowy FD
    J Infect Dis; 2008 Aug; 198(4):571-5. PubMed ID: 18613794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.
    McAdow M; Kim HK; Dedent AC; Hendrickx AP; Schneewind O; Missiakas DM
    PLoS Pathog; 2011 Oct; 7(10):e1002307. PubMed ID: 22028651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of a Multimechanistic Monoclonal Antibody Combination against Staphylococcus aureus Surgical Site Infections in Mice.
    Ortines RV; Wang Y; Liu H; Dikeman DA; Pinsker BL; Miller RJ; Kim SE; Ackerman NE; Rizkallah JF; Marcello LT; Cohen TS; Tkaczyk C; Sellman BR; Miller LS
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31138566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin.
    Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D
    J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Staphylococcus aureus Alpha-Toxin Is Conserved among Diverse Hospital Respiratory Isolates Collected from a Global Surveillance Study and Is Neutralized by Monoclonal Antibody MEDI4893.
    Tabor DE; Yu L; Mok H; Tkaczyk C; Sellman BR; Wu Y; Oganesyan V; Slidel T; Jafri H; McCarthy M; Bradford P; Esser MT
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5312-21. PubMed ID: 27324766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to capsular polysaccharide and clumping factor A prevent mastitis and the emergence of unencapsulated and small-colony variants of Staphylococcus aureus in mice.
    Tuchscherr LP; Buzzola FR; Alvarez LP; Lee JC; Sordelli DO
    Infect Immun; 2008 Dec; 76(12):5738-44. PubMed ID: 18809660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
    Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
    Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein A-neutralizing monoclonal antibody protects neonatal mice against Staphylococcus aureus.
    Thammavongsa V; Rauch S; Kim HK; Missiakas DM; Schneewind O
    Vaccine; 2015 Jan; 33(4):523-6. PubMed ID: 25488332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clumping factor A-mediated virulence during Staphylococcus aureus infection is retained despite fibrinogen depletion.
    Palmqvist N; Josefsson E; Tarkowski A
    Microbes Infect; 2004 Feb; 6(2):196-201. PubMed ID: 14998518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
    Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
    Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
    Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
    Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the mechanism of protection mediated by CS-D7, a monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB).
    Pancari G; Fan H; Smith S; Joshi A; Haimbach R; Clark D; Li Y; Hua J; McKelvey T; Ou Y; Drummond J; Cope L; Montgomery D; McNeely T
    Front Cell Infect Microbiol; 2012; 2():36. PubMed ID: 22919628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunogenicity of a Staphylococcus aureus-cholera toxin A
    Misra N; Wines TF; Knopp CL; Hermann R; Bond L; Mitchell B; McGuire MA; Tinker JK
    Vaccine; 2018 Jun; 36(24):3513-3521. PubMed ID: 29739718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies to Staphylococcus aureus capsular polysaccharides 5 and 8 perform similarly in vitro but are functionally distinct in vivo.
    Liu B; Park S; Thompson CD; Li X; Lee JC
    Virulence; 2017 Aug; 8(6):859-874. PubMed ID: 27936346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal
    Todd OA; Fidel PL; Harro JM; Hilliard JJ; Tkaczyk C; Sellman BR; Noverr MC; Peters BM
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164467
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies.
    Scarpa M; Piccinini R; Brun P; Grillo A; Palù G; Mengoli C; Daprà V; Castagliuolo I; Zecconi A
    J Dairy Res; 2010 May; 77(2):159-67. PubMed ID: 20030902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice.
    Yang Y; Qian M; Yi S; Liu S; Li B; Yu R; Guo Q; Zhang X; Yu C; Li J; Xu J; Chen W
    PLoS One; 2016; 11(2):e0149460. PubMed ID: 26926145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
    Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
    Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety, Tolerability, and Pharmacokinetics of MEDI4893, an Investigational, Extended-Half-Life, Anti-Staphylococcus aureus Alpha-Toxin Human Monoclonal Antibody, in Healthy Adults.
    Yu XQ; Robbie GJ; Wu Y; Esser MT; Jensen K; Schwartz HI; Bellamy T; Hernandez-Illas M; Jafri HS
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody-Mediated Protection against Staphylococcus aureus Dermonecrosis: Synergy of Toxin Neutralization and Neutrophil Recruitment.
    Yang C; Ruiz-Rosado JD; Robledo-Avila FH; Li Z; Jennings RN; Partida-Sanchez S; Montgomery CP
    J Invest Dermatol; 2021 Apr; 141(4):810-820.e8. PubMed ID: 32946878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.